tiprankstipranks
Trending News
More News >
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market
Advertisement

Sun Pharma Advanced Research Co. Ltd. (SPARC) Price & Analysis

Compare
2 Followers

SPARC Stock Chart & Stats


SPARC FAQ

What was Sun Pharma Advanced Research Co. Ltd.’s price range in the past 12 months?
Sun Pharma Advanced Research Co. Ltd. lowest stock price was ₹109.20 and its highest was ₹240.95 in the past 12 months.
    What is Sun Pharma Advanced Research Co. Ltd.’s market cap?
    Sun Pharma Advanced Research Co. Ltd.’s market cap is ₹45.94B.
      When is Sun Pharma Advanced Research Co. Ltd.’s upcoming earnings report date?
      Sun Pharma Advanced Research Co. Ltd.’s upcoming earnings report date is Nov 10, 2025 which is in 87 days.
        How were Sun Pharma Advanced Research Co. Ltd.’s earnings last quarter?
        Sun Pharma Advanced Research Co. Ltd. released its earnings results on Aug 04, 2025. The company reported -₹1.598 earnings per share for the quarter, missing the consensus estimate of N/A by -₹1.598.
          Is Sun Pharma Advanced Research Co. Ltd. overvalued?
          According to Wall Street analysts Sun Pharma Advanced Research Co. Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Sun Pharma Advanced Research Co. Ltd. pay dividends?
            Sun Pharma Advanced Research Co. Ltd. does not currently pay dividends.
            What is Sun Pharma Advanced Research Co. Ltd.’s EPS estimate?
            Sun Pharma Advanced Research Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sun Pharma Advanced Research Co. Ltd. have?
            Sun Pharma Advanced Research Co. Ltd. has 324,521,580 shares outstanding.
              What happened to Sun Pharma Advanced Research Co. Ltd.’s price movement after its last earnings report?
              Sun Pharma Advanced Research Co. Ltd. reported an EPS of -₹1.598 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.502%.
                Which hedge fund is a major shareholder of Sun Pharma Advanced Research Co. Ltd.?
                Currently, no hedge funds are holding shares in IN:SPARC

                Company Description

                Sun Pharma Advanced Research Co. Ltd.

                Sun Pharma Advanced Research Company Ltd. (SPARC) is a pharmaceutical research and development company focused on creating novel drug delivery systems and new chemical entities. Operating within the pharmaceutical and healthcare sectors, SPARC is dedicated to advancing innovative therapies to address unmet medical needs. The company's core activities include the development of proprietary technology platforms and conducting clinical trials to bring new drugs to market.

                Sun Pharma Advanced Research Co. Ltd. (SPARC) Earnings & Revenues

                SPARC Stock 12 Month Forecast

                Average Price Target

                ₹150.00
                ▲(6.95% Upside)
                {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"111":"₹111","228":"₹228","140.25":"₹140.3","169.5":"₹169.5","198.75":"₹198.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹150.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[111,140.25,169.5,198.75,228],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,160.95,160.1076923076923,159.26538461538462,158.4230769230769,157.58076923076922,156.73846153846154,155.89615384615385,155.05384615384614,154.21153846153845,153.36923076923077,152.52692307692308,151.68461538461537,150.84230769230768,{"y":150,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,160.95,160.1076923076923,159.26538461538462,158.4230769230769,157.58076923076922,156.73846153846154,155.89615384615385,155.05384615384614,154.21153846153845,153.36923076923077,152.52692307692308,151.68461538461537,150.84230769230768,{"y":150,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,160.95,160.1076923076923,159.26538461538462,158.4230769230769,157.58076923076922,156.73846153846154,155.89615384615385,155.05384615384614,154.21153846153845,153.36923076923077,152.52692307692308,151.68461538461537,150.84230769230768,{"y":150,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":227.4,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":227.55,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":215.95,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":215.95,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":217.4,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":200.7,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":160.05,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":112.65,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":146.35,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":145.95,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":198.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":160.95,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":160.95,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                Similar Stocks
                Company
                Price & Change
                Follow
                Aarti Drugs Limited
                Supriya Lifescience Limited
                Thyrocare Technologies Ltd
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis